Literature DB >> 9191668

Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients.

R Neidhardt1, M Keel, U Steckholzer, A Safret, U Ungethuem, O Trentz, W Ertel.   

Abstract

Interleukin-10 (IL-10) markedly inhibits lymphocyte and phagocytic functions, which are essential for an adequate immune response to invading microbes. Although various animal and clinical studies revealed an increased release of IL-10 during sepsis, alterations of circulating IL-10 after injury and potential relationships to severity of injury and clinical outcome are unknown. Injured patients (n = 417) showed elevated (p < 0.001) IL-10 levels throughout the observation period of 21 days compared with healthy volunteers (n = 137). Patients with severe injury (Injury Severity Score > or = 25 points) demonstrated significantly increased IL-10 levels compared with patients with minor trauma (Injury Severity Score < 25 points). Patients who died from injury or developed posttraumatic complications (sepsis, multiple organ dysfunction syndrome) revealed elevated IL-10 levels in comparison with injured patients with uneventful posttraumatic course. Thus, trauma causes an enhanced release of IL-10 dependent on the severity of injury. Because increased IL-10 levels are significantly related to posttraumatic complications, IL-10 may be involved in their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191668     DOI: 10.1097/00005373-199705000-00017

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  46 in total

1.  [Clinical course and prognostic significance of immunological and functional parameters after severe trauma].

Authors:  S Lendemans; E Kreuzfelder; C Waydhas; D Nast-Kolb; S Flohé
Journal:  Unfallchirurg       Date:  2004-03       Impact factor: 1.000

2.  Change of TH1/TH2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection.

Authors:  Yong-hao Yu; Nai-qiang Cui; Qiang Fu; Jun Li
Journal:  Chin J Integr Med       Date:  2005-06       Impact factor: 1.978

3.  Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis.

Authors:  Marcin F Osuchowski; Judith Connett; Kathleen Welch; Jill Granger; Daniel G Remick
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

4.  Circulating cytokines after hip and knee arthroplasty: a preliminary study.

Authors:  Kalpesh Shah; Aslam Mohammed; Sanjeev Patil; Angus McFadyen; R M D Meek
Journal:  Clin Orthop Relat Res       Date:  2008-10-22       Impact factor: 4.176

5.  Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome.

Authors:  M N Gong; B T Thompson; P L Williams; W Zhou; M Z Wang; L Pothier; D C Christiani
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

6.  Development of a murine model of blunt hepatic trauma.

Authors:  Jean A Nemzek-Hamlin; Haejin Hwang; Joseph A Hampel; Bi Yu; Krishnan Raghavendran
Journal:  Comp Med       Date:  2013-10       Impact factor: 0.982

7.  Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock.

Authors:  Ranjit S Chima; Paul W Hake; Giovanna Piraino; Prajakta Mangeshkar; Alvin Denenberg; Basilia Zingarelli
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

8.  Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune response.

Authors:  Tamara Stampalija; Roberto Romero; Steven J Korzeniewski; Piya Chaemsaithong; Jezid Miranda; Lami Yeo; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-06-25

9.  IL-6 predicts organ dysfunction and mortality in patients with multiple injuries.

Authors:  Michael Frink; Martijn van Griensven; Philipp Kobbe; Thomas Brin; Christian Zeckey; Bernhard Vaske; Christian Krettek; Frank Hildebrand
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-27       Impact factor: 2.953

10.  Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies.

Authors:  Ling Zeng; Wei Gu; Kehong Chen; Dongpo Jiang; Lianyang Zhang; Dingyuan Du; Ping Hu; Qing Liu; Suna Huang; Jianxin Jiang
Journal:  Crit Care       Date:  2009-11-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.